Lenzetto (Estradiol)

Lenzetto (estradiol) is used in hormone replacement therapy to address conditions related to low estrogen levels.

• Menopausal symptoms: reduces frequency and severity of hot flashes, night sweats, and improves mood.
• Estrogen deficiency: restores systemic estrogen levels, supporting bone density and vaginal health.
• Hypoestrogenic states post‑oophorectomy: provides necessary estrogen replacement to mitigate surgical menopause effects.

• Estradiol in Lenzetto penetrates the skin and enters systemic circulation, where it binds to intracellular estrogen receptors ERα and ERβ. Receptor activation modulates gene transcription, leading to increased synthesis of proteins that maintain bone mineralization, regulate lipid metabolism, and support the growth and maintenance of urogenital epithelium. The transdermal delivery bypasses first‑pass hepatic metabolism, providing more stable plasma concentrations.

Transdermal estradiol may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Skin irritation at the application site: redness, itching, or rash.
• Headache: mild to moderate intensity.
• Nausea: occasional upset stomach.
• Breast tenderness: discomfort or swelling.
• Mood changes: irritability or mild depression.

Serious or Rare Side Effects

• Thromboembolic events: deep vein thrombosis or pulmonary embolism.
• Stroke or transient ischemic attack.
• Myocardial infarction: heart attack symptoms.
• Hepatic dysfunction: jaundice or abnormal liver enzymes.
• Endometrial hyperplasia or carcinoma: abnormal uterine bleeding.

Before prescribing Lenzetto, clinicians should evaluate patient risk factors and follow safety guidelines.

• Cardiovascular assessment: review history of thromboembolism, stroke, or myocardial infarction.
• Breast health evaluation: perform regular examinations and consider mammography.
• Liver function monitoring: check hepatic enzymes in patients with liver disease.
• Lowest effective dose: use the minimal patch strength needed to control symptoms.
• Pregnancy avoidance: contraindicated in pregnancy; ensure effective contraception.
• Store at room temperature: keep in original pouch, protect from moisture and direct sunlight.

Estradiol can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase estradiol plasma levels.
• Anticoagulants (e.g., warfarin): heightened risk of bleeding.
• Oral contraceptives containing estrogen: additive estrogenic effects.
• Certain antiretrovirals (e.g., protease inhibitors): may raise estradiol concentrations.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors (e.g., fluoxetine): may modestly increase estradiol levels.
• Thyroid hormone replacement: monitor thyroid function tests.
• Antihypertensive agents: observe blood pressure changes.
• Herbal supplements (e.g., St. John’s wort): potential reduction of estradiol effectiveness.